About this trial

Patients undergoing cystectomy for either oncological or non-oncological indications are prospectively enrolled following informed consent. This study design incorporates a comprehensive medical history, detailed prospective documentation of clinicopathological parameters, and serial measurements of infectious markers pre- and post-operatively. In-hospital complications are meticulously recorded, and long-term outcomes assessed through structured follow-up interviews at 3, 6, and 12 months. These follow-ups utilize standardized questionnaires to evaluate post-discharge infectious complications and gather patients' perspectives on their in-hospital experiences, providing a robust understanding of both clinical outcomes and patient-reported experiences.

Eligibility criteria

Qualifiers

Disease which requires removal of the urinary bladder

Disqualifiers

Patient does not want to participate

Trial design

Treatments tested in this trial

  • Cystectomy

Treatment groups

No treatment groups listed

Locations

1
Urology Department - LMU Klinikum81377, MunichOutside U.S./Canada, Germany

Sponsors and collaborators

Ludwig-Maximilians - University of Munich

Lead sponsor